UBS initiates coverage with positive outlook
Shares of LEAP India, a leading logistics firm, experienced a significant rally on Monday, gaining up to 5 percent in early trading. The surge followed the initiation of coverage by global investment bank UBS, which assigned the stock a 'Buy' rating. UBS characterised LEAP as a key beneficiary of the modernisation of India's supply chain infrastructure.
Market reaction and price targets
The stock hit an intraday high of Rs 147.50 on the National Stock Exchange (NSE). While some profit booking caused the price to settle slightly lower, it was trading at Rs 145.31, up 3.45 percent, as of 12:45 p.m.
UBS has set a target price of Rs 175 per share. This valuation implies an upside potential of nearly 25 percent when compared to the stock's closing level on Friday.
Fundamental projections and growth drivers
LEAP operates India's largest pooled logistics-asset network, providing pallets, containers, and material-handling equipment on a rental basis. UBS highlighted that the company is well-positioned to benefit from currently low palletisation and pooling penetration rates in the market, alongside increasing warehouse formalisation and a growing demand for supply-chain efficiency.
The brokerage forecasts strong fundamental growth for the company. It expects revenue to grow at a compound annual growth rate (CAGR) of 19 percent and EBITDA to grow at a 21 percent CAGR over the period from FY26 to FY31. A key driver for this growth is the increasing mix of movement hire, which is expected to improve pallet yields and overall asset productivity.
Margin expansion and returns
UBS projects significant improvements in LEAP's profitability metrics. The brokerage expects EBITDA margins to increase from 49.5 percent to 53.8 percent over the forecast period. Additionally, the return on capital employed (ROCE) is projected to rise from 8.4 percent to 14.7 percent by FY31.
"LEAP's nationwide network and scale advantages position it to capture industry growth, while delivering improving returns and free cash flow," UBS stated in its report.
